Stamler David Allen
Visual SEC Form 4 history across 1 companies, 1 transactions and 1 filings.
Open-market buy performance
90-day forward return on this insider's open-market purchases
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for some of their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Net value flow
Buys minus sells
Transaction texture
Ownership and ticket size
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
buy at ALTERITY THERAPEUTICS LTD on Aug 31, 2026 valued at $23,810.
Review SEC filingNo open-market insider sale is available.
Associated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| ATHE | Stamler David Allen | CEO | buy | 47.6k | -$2.38M | P | — | 09/08 | 08/31 |
Stamler David Allen Insider Activity FAQ
SEC Form 4 context
Who is Stamler David Allen?
Stamler David Allen is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002130205.
Which companies has Stamler David Allen reported transactions for?
ALTERITY THERAPEUTICS LTD
When was Stamler David Allen's latest insider buy?
buy at ALTERITY THERAPEUTICS LTD on Aug 31, 2026 valued at $23,810.
When was Stamler David Allen's latest insider sale?
No open-market insider sale is available for this period.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.